Literature DB >> 16695916

Thyroxine Turnover and Transport in Laennec's Cirrhosis of the Liver.

M Inada1, K Sterling.   

Abstract

Studies of the metabolism of thyroxine in 14 cases of cirrhosis revealed a variety of deviations from normal. In addition to radiothyroxine turnover studies, determinations were made of the free thyroxine fractions and free thyroxine iodine concentrations in serum (magnesium precipitation method) as well as the maximal binding capacities of thyroxine-binding alpha globulin (TBG) and thyroxine-binding prealbumin (TBPA) by reverse flow paper electrophoresis in a glycine acetate system at pH 8.6.All cases of cirrhosis exhibited diminutions in TBPA capacities but their TBG capacities showed a wide scatter (13.4 to 41.6 mug/100 ml). The free thyroxine fraction was quite variable, with distinct elevations in nine of the 17 sera.The binding proteins appeared to be determinants of the free thyroxine fraction, which in turn, appeared to be a direct determinant of the half-time of turnover. These inferences did not exclude other possible factors including diminished hepatic uptake and metabolism of the hormone in liver disease.Despite considerable alterations in biological half-times, free thyroxine values, and binding proteins, it was remarkable that the absolute hormone disposal was normal in all 14 patients with cirrhosis.

Entities:  

Year:  1967        PMID: 16695916      PMCID: PMC297129          DOI: 10.1172/JCI105620

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Reverse-flow zone electrophoresis; a method for determining the thyroxine-binding capacity of serum protein.

Authors:  J ROBBINS
Journal:  Arch Biochem Biophys       Date:  1956-08       Impact factor: 4.013

2.  Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease.

Authors:  K STERLING; R B CHODOS
Journal:  J Clin Invest       Date:  1956-07       Impact factor: 14.808

3.  Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects.

Authors:  K STERLING; J C LASHOF; E B MAN
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

4.  Observations concerning the binding of thyroid hormones in sera of normal subjects of varying ages.

Authors:  L W Braverman; N A Dawber; S H Ingbar
Journal:  J Clin Invest       Date:  1966-08       Impact factor: 14.808

5.  A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration.

Authors:  S H Ingbar; L E Braverman; N A Dawber; G Y Lee
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

6.  Factors influencing the concentration of free and total thyroxine in patients with nonthyroidal disease.

Authors:  G Bernstein; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1966-02       Impact factor: 5.958

7.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation.

Authors:  K Sterling; M A Brenner
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

8.  An analysis of published data on thyroxine turnover in human subjects.

Authors:  T H Oddie; J H Meade; D A Fisher
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

9.  Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.

Authors:  J H Oppenheimer; G Bernstein; J Hasen
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

10.  Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients.

Authors:  E L Socolow; K A Woeber; R H Purdy; M T Holloway; S H Ingbar
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

View more
  10 in total

1.  The interpretation of the serum protein-bound iodine: A review.

Authors:  J D Acland
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

2.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Prognostic value of thyroid hormone levels in patients evaluated for liver transplantation.

Authors:  D H Van Thiel; M Udani; R R Schade; A Sanghvi; T E Starzl
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

4.  An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.

Authors:  I J Chopra
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

5.  Thyroid and pituitary hormone responses to TRH in advanced nonalcoholic liver disease.

Authors:  D H Van Thiel; R Tarter; J S Gavaler; R R Schade; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

6.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  Studies of peripheral thyroxine distribution in thyrotoxicosis and hypothyroidism.

Authors:  J T Nicoloff; J T Dowling
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

8.  Evaluation of serum total thyroxine and triiodothyronine and their serum fractions in nonthyroidal illness secondary to congenital heart disease. Studies before and after surgery.

Authors:  A Belgorosky; G Weller; E Chaler; S Iorcansky; M A Rivarola
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

9.  Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-14C.

Authors:  M A Rothschild; M Oratz; D Zimmon; S S Schreiber; I Weiner; A Van Caneghem
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

10.  Clinical evaluation of thyroxine-binding globulin (TBG) as a marker of liver tumors.

Authors:  S Terui
Journal:  Eur J Nucl Med       Date:  1984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.